Four Drugs Top Three for Upfront Treatment of Multiple Myeloma

(MedPage Today) -- SAN DIEGO -- Patients with newly diagnosed multiple myeloma had almost a 60% improvement in progression-free survival (PFS) if they received the anti-CD38 daratumumab (Darzalex) in addition to standard therapy, a large randomized...
Source: MedPage Today Hematology/Oncology - Category: Hematology Source Type: news